Messino Cancer Center — Asheville, North Carolina

Messino Cancer Center is a clinical research site located in Asheville, North Carolina, United States 28806.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Messino Cancer Center has participated in 12 clinical trials with 8 currently active.

Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer, Lymphoma, Mantle-Cell, Metastatic HER2-positive Breast Cancer.

Sponsors: Zenith Epigenetics, Loxo Oncology, Inc., Jazz Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Messino Cancer Center?

Messino Cancer Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Messino Cancer Center conducted?

Messino Cancer Center has 12 clinical trials on record, with 8 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer, Lymphoma, Mantle-Cell, Metastatic HER2-positive Breast Cancer.

Is Messino Cancer Center accredited by Crixeo Health?

Messino Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Messino Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.